Publications | Grants | Research Degrees


Publications

Baker A, Richmond R, Lewin T, Kay-Lambkin F. Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial. Australian and New Zealand Journal of Psychiatry 2010; 44: 342-350.

Battisti R, Roodenrys S, Johnstone SJ, Pesa N, Hermens D, Solowij N. Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution. Psychopharmacology 2010; 212: 613-624.

Butler T, Schofield P, Greenberg D, Allnutt S, Indig D, Carr V, D'Este C, Mitchell P, Knight L, Ellis A. Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor. Australian and New Zealand Journal of Psychiatry 2010; 44: 1137-1143.

Campbell L, McCabe K, Leadbeater K, Schall U, Loughland C, Rich D. Visual scanning of faces in 22q11.2 deletion syndrome: Attention to the mouth or the eyes? Psychiatric Research 2010; 177: 211-215.

Carr VJ. Beauty and belief. William James and the aesthetics of delusions in schizophrenia. Cognitive Neuropsychiatry 2010; 15: 181-201.

Catts S, Evans R, O'Toole B, Carr V, Lewin T, Neil A, Harris M, Frost A, Crissman B, Eadie K. Is a national framework for implementing early psychosis services necessary? Results of a survey of Australian mental health service directors. Early Intervention in Psychiatry 2010; 4: 25-30.

Chen J, Huang XF. The PI3K/Akt pathway may play a key role in social isolation-caused schizophrenia (letter). Synapse 2010; 63: 476-483.

Cullen A, Dickson H, West S, Morris R, Mould G, Hodgins S, Murray R, Laurens K. Neurocognitive performance in children aged 9–12 years who present putative antecedents of schizophrenia. Schizophrenia Research 2010; 121: 15-23.

Dalton VS, Zavitsanou K. Cannabinoid effects on CB1 receptor density in the adolescent brain: An autoradiographic study using the synthetic cannabinoid HU210. Synapse 2010; 64: 845-854.

Dalton VS, Zavitsanou K. Differential treatment regimen-related effects of cannabinoids on D1 and D2 receptors in adolescent and adult rat brain. Journal of Chemical Neuroanatomy 2010; 40: 272-280.

Deng C, Chen J, Hu C, Huang X-F. What is the mechanism for aripiprazole’s effect on reducing olanzapine-induced obesity? (Letter). Journal of Clinical Psychopharmacology 2010; 30: 480-481.

Deng C, Weston-Green K, Huang XF. The role of histaminergic H1 and H3 receptors in food intake: A mechanism for antipsychotic-induced weight gain? Progress in Neuropsychopharmacology and Biological Psychiatry 2010; 34: 1-4.

Duncan C, Webster MJ, Rothmond D, Bahn S, Elashoff M, Shannon Weickert C. Prefrontal GABAA receptor alpha subunit expression in normal postnatal human development and schizophrenia. Journal of Psychiatric Research 2010; 44: 673-681.

Duffy L, Cappas E, Lai D, Boucher A, Karl T. Cognition in transmembrane domain Neuregulin 1 mutant mice. Neuroscience 2010; 170: 800-807.

Elliott D, Shannon Weickert C, Garner B. Apolipoproteins in the brain: implications for neurological and psychiatric disorders. Clinical Lipidology 2010; 5: 555-573.

Fillman S, Duncan C, Webster M, Elashoff M, Shannon Weickert C. Developmental co-regulation of the β and γ GABAA receptor subunits with distinct α subunits in the human dorsolateral prefrontal cortex. International Journal of Developmental Neuroscience 2010; 28: 513-519.

Foland-Ross L, Altshuler L, Bookheimer S, Lieberman M, Townsend J, Penfold C, Moody T, Ahlf K, Shen J, Madsen S, Rasser P, Toga A, Thompson P. Amygdala reactivity in healthy adults is correlated with prefrontal cortical thickness. Journal of Neuroscience 2010; 30: 16673-16678.

Fung S, Webster MJ, Sivagnanasundaram S, Duncan C, Elashoff M, Shannon Weickert C. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. American Journal of Psychiatry 2010; 167: 1479-1488.

Ishiguro H, Koga M, Horiuchi Y, Noguchi E, Morikawa M, Suzuki Y, Arai M, Niizato K, Iritani S, Itokawa M, Inada T, Iwata N, Ozaki N, Ujike H, Kunugi H, Sasaki T, Takahashi M, Watanabe Y, Someya T, Kakita A, Takahashi H, Nawa H, Arinami T. Supportive evidence for reduced expression of GNB1L in schizophrenia. Schizophrenia Bulletin 2010; 36: 756-765.

Jamadar S, Hughes M, Fulham R, Michie P, Karayanidis F. The spatial and temporal dynamics of anticipatory preparation and response inhibition in task-switching. Neuroimage 2010; 51: 432-449.

Jamadar S, Michie P, Karayanidis F. Sequence effects in cued task switching modulate response preparedness and repetition priming processes. Psychophysiology 2010; 47: 365-386.

Kadota Y, Cooper G, Burton A, Lemon J, Schall U, Lloyd A, Vollmer-Conna U. Autonomic hypervigilance in post-infective fatigue syndrome. Biological Psychology 2010; 85: 97-103.

Karl T, Chesworth R, Duffy L, Herzog H. Schizoprhenia-relevant behaviours in a genetic mouse model for Y2 deficiency. Behavioural Brain Research 2010; 207: 437-440.

Karl T, Chesworth R, Duffy L, Herzog H. Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor. Neuropeptides 2010; 44: 233-239.

Lian J, Huang XF, Pai N, Deng C. Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole (Letter). Progress in Neuropsychopharmacology & Biological Psychiatry 2010; 34: 1157-1158.

Long L, Chesworth R, Arnold JC, Karl T. A follow-up study: Acute behavioural effects of delta9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice. Psychopharmacology 2010; 211: 277-289.

Long L, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T. A behavioural comparison of acute and chronic delta-9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. International Journal of Neuropsychopharmacology 2010; 13: 861-867.

Lorenzetti V, Lubman D, Whittle S, Solowij N, Yucel M. Structural MRI findings in long-term cannabis users: What do we know? Substance Use and Misuse 2010; 45: 1787-1808.

Loughland C, Allen J, Gianacasa L, Schofield P, Lewin T, Hunter M, Carr V. Brief neuropsychological profiles in psychosis: a pilot study using the Audio Recorded Cognitive Screen (ARCS). Acta Neuropsychiatrica 2010; 22: 243-252.

Loughland C, Draganic D, McCabe K, Richards J, Nasir A, Allen J, Catts S, Jablensky A, Henskens F, Michie P, Mowry B, Pantelis C, Schall U, Scott R, Tooney P, Carr V. The Australian Schizophrenia Research Bank: A database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia. Australian and New Zealand Journal of Psychiatry 2010; 44: 1029-1035.

Luberg K, Wong J, Shannon Weickert C, Timmusk T. Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. Journal of Neurochemistry 2010; 113: 952-964.

Marsh P, Green M, Russel T, McGuire J, Harris A, Coltheart M. Remediation of facial emotion recognition in schizophrenia: Functional predictors, generalizability, and durability. American Journal of Psychiatric Rehabilitation 2010; 13: 143–170.

Matheson S, Green M, Loo C, Carr V. Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: A systematic meta-review. Schizophrenia Research 2010; 118: 201-210.

Morris RW, Fung S, Rothmond DA, Richards AB, Ward S, Noble P, Woodward R, Weickert CS, Winslow J. Effects of testosterone on prepulse inhibition in male rhesus macaques during pubertal development. Psychoneuroendocrinology 2010; 35: 896-905.

Rasser P, Schall U, Peck G, Cohen M, Johnston P, Khoo K, Carr V, Ward P, Thompson P. Cerebellar grey matter deficits in first-episode schizophrenia mapped using cortical pattern matching. NeuroImage 2010; 53: 1175-1180.

Saravolac EG, Wong JP, Cairns MJ. Recent patents in antiviral siRNAs. Recent Patents on Anti-infective Drug Discovery 2010; 5: 44-57.

Shannon Weickert C, Sheedy D, Rothmond D, Dedova I, Fung S, Garrick T, Wong J, Harding A, Sivagnanansundaram S, Hunt C, Duncan C, Sundqvist N, Tsai S, Anand J, Draganic D, Harper C. Selection of reference gene expression in a schizophrenia brain cohort. Australian and New Zealand Journal of Psychiatry 2010; 44: 59-70.

Sparks A, McDonald S, Lino B, O'Donnell M, Green M. Social cognition, empathy and functional outcome in schizophrenia. Schizophrenia Research 2010; 122: 172-178.

Todd J, Myers R, Pirillo R, Drysdale K. Neuropsychological correlates of auditory perceptual inference: A mismatch negativity (MMN) study. Brain Research 2010; 1310: 113-123.

Todd J, Robinson J. The use of conditional inference to reduce prediction error — A mismatch negativity (MMN) study. Neuropsychologia 2010; 48: 3009-3018.

Verdurand M, Dalton VS, Zavitsanou K. GABA-A receptor density is altered by cannabinoid treatment in the hippocampus of adult but not adolescent rats. Brain Research 2010; 1315: 238-245.

Weston-Green K, Huang XF, Deng C. Sensitivity of the female rat to Olanzapine-induced weight gain: Far from the clinic? (Letter). Schizophrenia Research 2010; 116: 299-300.

Wong J, Christopher M, Salazar A, Sun LQ, Viswanathan S, Wang M, Saravolac E and Cairns M. Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza. Frontiers in Bioscience 2010; 2: 791-800.

Wong J, Hyde TM, Cassano HL, Deep-Soboslay A, Kleinman JE, Shannon Weickert C. Promoter specific alterations of BNDF mRNA in schizophrenia. Neuroscience 2010; 169: 1071-1084.

Zavitsanou K, Dalton V, Wang HQ, Newson P, Chahl L. Receptor changes in brain tissue of rats treated as neonates with capsaicin. Journal of Chemical Neuroanatomy 2010; 39: 248-255.

Zavitsanou K, Wang HQ, Dalton VS, Nguyen V. Cannabinoid administration increases 5HT1A receptor binding and mRNA expression in the hippocampus of adult but not adolescent rats. Neuroscience 2010; 169: 315-324.

Grants

Schizophrenia Research Institute Administered

Carr V, Draganic D, Duffy L. Australian Schizophrenia Research Bank (Robotics Equipment). Ian Potter Foundation, 2010 ($45,000).

Carr V, Draganic D, Duffy L. Australasian Schizophrenia Conference 2010. Ian Potter Foundation, 2010 ($10,000).

Carr V, Draganic D, Duffy L. Australasian Schizophrenia Conference 2010. Mental Health Council of Australia (Mental Health Conference Funding Program), 2010, ($10,000).

Carr V, Draganic D, Duffy L. Australasian Schizophrenia Conference 2010. NSW Office of Science and Medical Research, 2010 ($10,000).

Carr V, Draganic D, Jablensky A. Technical Officer for the Australian Schizophrenia Research Bank. Ron and Peggy Bell Foundation, 2010-2012 ($36,000).

Carr V, Schall U, Scott R, Jablensky A, Mowry B, Michie P, Catts S, Henskens F, Pantelis C, Loughland C. Perkin-Elmer Janus Liquid Handling Workstation (Mini 4-Tip Platform). NHMRC Equipment Grant, 2009 ($7,162).

Schall U, Rasser P, Loughland C. ASRB Virtual Brain Bank. NHMRC Equipment Grant, 2010 ($4,581).

Host Institution Administered

Butler T, Schofield P, Greenberg D, Weatherburn D, Wilhelm K, Carr V, D'Este C, Jones A. Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor. NHMRC Project Grant, 2010-2014 ($1,261,750).

Cairns M, Scott R, Tooney P, Rostas J, Brichta A. Molecular and cellular characterisation of schizophrenia associated dysfunction in microRNA biogenesis. NHMRC Project Grant, 2010-2014 ($478,500).

Carr V, Laurens K, Holbrook A, Lenroot R, Brinkman S, Bore M, Maloney E, Smith M, Matthews R. The NSW Child Development Study. ARC Linkage Projects Grant, 2011-2014, ($429,099).

Carr V, Michie P, Lenroot R. Longitudinal Child Health Study: Pilot Study. Australian Rotary Health Research Fund Mental Health of Young Australians Grant, 2010 ($16,500).

Dedova I. Identifying the neuropathological mechanisms of antipsychotic drug-induced Parkinsonism in schizophrenia. University of Western Sydney Research Grant, 2010 ($21,900).

Fung S, Shannon Weickert C. Sex-steroid driven molecular development of the hippocampus in non-human primate adolescence. UNSW Early Career Researcher Grant. 2010 ($20,000).

Han M. Understanding the role of neuregulin-1 genetic polymorphisms in patients with schizophrenia. NHMRC Australia-China Exchange Fellowship. 2010-2013 ($318,600).

Hanlon MC, Schall U. RHD Completion Scholarship. University of Newcastle, 2010 ($10,000).

Henskens F, Loughland C, McCabe K, Carr V. Server for the Australian Schizophrenia Research Bank. University of Newcastle, 2010 ($20,000).

Hodgson DM, Nakamura T, Michie PT, Hunter M, Todd J. Memory-related endophenotypes in the two-hit model of schizophrenia. University of Newcastle Strategic Pilot Research Grant, 2010 ($19,873).

Huang XF, Deng C. Schizophrenia: Prevention and treatment of atypical antipsychotic drug-induced obesity. NHMRC Project Grant, 2010-2014 ($399,250).

Karl T. Maternal infection: Part of the two-hit hypothesis of schizophrenia. International Science Linkages Science Academies Program, Australian Academy of Science, 2010-2011 ($7,600).

Karl T. Mechanisms and neuroplasticity of environmental enrichment. UNSW Goldstar Grant, 2010 ($40,000).

Karl T. Mouse housing, animal welfare and data reliability. Perpetual Trustees Grant, 2010 ($19,000).

Kelly B, Stain H, Lewin T, Carr V, Fragar L,Perkins D, Fuller J. Living in a rural community: A longitudinal study of the course and outcome of mental health and wellbeing. NHMRC Project Grant, 2010-2014 ($805,650).

Kumarasinghe N. RHD Completion Scholarship. University of Newcastle, 2010 ($10,000).

Long L. Society for Neurosciences Meeting. CASS Foundation Travel Grant, 2010 ($1,080).

McCabe K. RHD Completion Scholarship. University of Newcastle, 2010 ($10,000).

Michie P. The effects of maternal infection on NMDA-related electrophysiological, behavioural and biochemical measures relevant to schizophrenia. University of Newcastle Near Miss Grant, 2010 ($25,000).

Schofield P, Fullterton J, Shannon Weickert C, Donald J. Sialyltransferase in the bipolar and schizophrenic brain: examining the role of a novel generalised susceptibility gene. NHMRC Project Grant, 2010-2014 ($494,500).

Shannon Weickert C, Garner B, Fullerton J. Neuregulin dependent neuronal migration and schizophrenia. NHMRC Project Grant, 2010-2013 ($289,000).

Vercammen A, Loo C, Weickert T. Transcranial Direct Current Stimulation as an adjunctive treatment for cognitive deficits and residual auditory hallucinations in schizophrenia. NARSAD Young Investigator Award, 2010-2011 ($60,000).

Wong J. Society for Neurosciences Meeting. CASS Foundation Travel Grant, 2010 ($3,990).